The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 26,101–26,200 of 31,469
Lee, W., Lingard, J. M., & Bermingham, M. (2007) · PubMed · Cited by 3
Related Factors of Insulin Resistance in Korean Children: Adiposity and Maternal Insulin Resistance
Cho, Y. G., Kang, J.-H., Hur, Y., Song, J., & Lee, K. (2011) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph8124596 · Cited by 3
Jain, N. (2012) · Journal of Bioengineering and Biomedical Sciences · doi:10.4172/2155-9538.1000114 · Cited by 3
Oh, E., Han, J. H., Han, S. M., Im, J. A., Rhee, E., Park, C., Oh, K. W., & Lee, W. (2009) · Korean Diabetes Journal · doi:10.4093/kdj.2009.33.4.279 · Cited by 3
Lee, H., Park, M.-K., Lee, K. I., An, Y.-J., Kim, J. M., Park, J. Y., Han, Y. S., Hong, S. H., Choi, S.-S., Yoo, Y. H., et al. (2007) · The Journal of Korean Diabetes Association · doi:10.4093/jkda.2007.31.1.63 · Cited by 3
Lazzeri, C., Valente, S., D’Alfonso, M. G., Chiostri, M., & Gensini, G. F. (2014) · IJC Metabolic & Endocrine · doi:10.1016/j.ijcme.2014.02.003 · Cited by 3
Stewart, C. P., Christian, P. S., Schulze, K. J., Shah, U. S., Subedi, G., LeClerq, S. C., & Khatry, S. K. (2010) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174410000103 · Cited by 3
Effect of active smoking on glucose tolerance and lipid profile
Parchwani, D. N., Upadhyah, A., & Chandan, D. (2012) · International Journal of Medical Science and Public Health · doi:10.5455/ijmsph.2013.2.20-25 · Cited by 3
Newborn Size and Body Composition as Predictors of Insulin Resistance and Diabetes in the Parents
Veena, S. R., Krishnaveni, G. V., & Fall, C. H. D. (2012) · Diabetes Care · doi:10.2337/dc12-0177 · Cited by 3
Positive Correlation of Resistin with Blood Lipids in Gestational Diabetes
Zare, Z., Meshkibaf, M. H., Hamaitkhah, et al. (2014) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 3
Karásek, D., Vaverková, H., Fryšák, Z., Orság, J., Novotný, D., Halenka, M., & Slavík, L. (2012) · PubMed · Cited by 3
Minoura, A., Wang, D.-H., Sato, Y., Zou, Y., Sakano, N., Kubo, M., Takemoto, K., Masatomi, C., & Ogino, K. (2014) · PubMed · doi:10.18926/amo/52652 · Cited by 3
Suh, Y. S., Lee, I., & Kim, D. H. (2007) · The Journal of Korean Diabetes Association · doi:10.4093/jkda.2007.31.2.136 · Cited by 3
Ji, Z., Dai, Z., Huang, Y., Martins, H. A., & Xu, Y. (2011) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-011-0372-9 · Cited by 3
Metabolic Syndrome Biomarkers in Type II Diabetic Ethiopian Patients
Tadesse, F. G. (2014) · Journal of Metabolic Syndrome · doi:10.4172/2167-0943.1000139 · Cited by 3
Casulari, L. A., Dondi, D., Celotti, F., da Silva, F. V. P., Reis, C. E. G., & da Costa, T. H. M. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0057-9 · Cited by 3
Hiperandrogenismo ovárico funcional y síndrome del ovario poliquístico en la adolescencia
Toda, L. I., & Potau, N. (2006) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(06)71167-6 · Cited by 3
Insulin resistance and blood pressure in Nigerian type 2 diabetic patients
Bakari, A. G., & Onyemelukwe, G. (2009) · International Journal of Medicine and Medical Sciences · doi:10.5897/ijmms.9000139 · Cited by 3
Glomerular hyperfiltration in hypogonadotropic hypogonadic patients: Overlooking a cache?
Gözükara, K. H., Arslan, A., Görür, S., Rifaioğlu, M. M., & Çarlıoğlu, A. (2015) · International Urology and Nephrology · doi:10.1007/s11255-015-0995-z · Cited by 3
Maple-Brown, L. J., Hodge, A. M., Cunningham, J., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03445.x · Cited by 3
Rhee, S. Y., Chon, S., Oh, S., Kim, S. W., Kim, J. W., Kim, Y. S., & Woo, J. (2006) · The Journal of Korean Diabetes Association · doi:10.4093/jkda.2006.30.3.198 · Cited by 3
RetractedUehara, S. K., & Rosa, G. (2011) · PubMed · doi:10.1590/s0212-16112011000200009 · Cited by 3
O’Donoghue, G., Kennedy, A., Andersen, G. S., Durkan, E., Thybo, T., Sinnott, M., Nolan, J. J., & O’Gorman, D. J. (2015) · Trials · doi:10.1186/s13063-015-1042-1 · Cited by 3
Nishikawa, T., Okamura, T., Shima, A., Kawatsu, Y., Sugiyama, D., Kadota, A., Morimoto, A., Tatsumi, Y., Godai, K., & Miyamatsu, N. (2015) · Diabetology International · doi:10.1007/s13340-015-0241-z · Cited by 3
Adiponectin and uric acid in pre-diabetes and early type 2 diabetes mellitus
Vitkus, D., & Borovkienė, R. (2008) · Cited by 3
Han, H. J., Shin, J., Lee, C. B., Park, Y. S., Kim, D. S., Ahn, Y. H., Kim, T. W., & Choi, W. H. (2007) · The Korean Journal of Internal Medicine · Cited by 2
Hoseen, M. I., Al-Aleem, D. I. A., & FaragAllah, E. M. (2010) · Cited by 3
Tibana, R. A., Teixeira, T. G., de Farias, D. L., Silva, A. D. O., Madrid, B., Vieira, A., Franz, C. B., Bálsamo, S., Júnior, P. D. S., & Prestes, J. (2012) · Cited by 3
Bodo, M. J., Jimenez, E. Y., Conn, C. A., Dye, A., Pomo, P., Kolkmeyer, D., Orlando, R. A., & Kong, A. S. (2016) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2015-0260 · Cited by 3
Hou, J., Zhang, X., Wang, X., et al. (2013) · Lecture notes in electrical engineering · doi:10.1007/978-94-007-7618-0_52 · Cited by 3
Yoo, K. H., Oh, I. M., Park, J. E., et al. (2012) · The Korean Journal of Obesity · doi:10.7570/kjo.2012.21.3.175 · Cited by 3
Park, H., Park, S. E., Park, C., Lim, S. Y., Lee, W., Oh, K.-W., Park, S. W., & Rhee, E. (2016) · BMC Pulmonary Medicine · doi:10.1186/s12890-016-0190-8 · Cited by 3
Nazmy, M., & Abd‐Elghany, M. I. (2015) · International Research Journal of Medicine and Medical Sciences · Cited by 3
Mahesan, A. M., Ogunyemi, D. A., Kim, E. H., Paul, A. B. M., & Chen, Y. I. (2016) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2016.61011 · Cited by 3
Yang, K.-M. (2015) · 한국식품조리과학회지 · doi:10.9724/kfcs.2015.31.2.118 · Cited by 3
Wierzbicki, A. S., Hardman, T. C., Cheung, J., et al. (2000) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001097 · Cited by 3
Resistin and Cardiac Remodeling in Patients with Obstructive Sleep Apnea
Cherneva, R. V. (2014) · Journal of Pulmonary & Respiratory Medicine · doi:10.4172/2161-105x.1000186 · Cited by 2
Zaki, H. F., Mansour, S. M., & El-Denshar, E.-E.-D. (2013) · Pharmacologia · doi:10.5567/pharmacologia.2013.186.196 · Cited by 3
Kurosaka, Y., Kitamura, H., Yamauchi, H., et al. (2014) · 体力科學 · doi:10.7600/jspfsm.63.223 · Cited by 3
Ootani, K., Hashimoto, S., Hayashi, S., Kimura, T., & Naito, M. (2011) · Journal for the Integrated Study of Dietary Habits · doi:10.2740/jisdh.22.114 · Cited by 3
Geloneze, B., Carolina, A., Vasques, C. J., França, C., Pareja, J. C., de Queiroz, E. C., & Tambascia, M. A. (2009) · Americanae (AECID Library) · Cited by 3
Baltrukova, A. N., Берлев, И. В., & Berstein, L. M. (2016) · Journal of obstetrics and women s diseases · doi:10.17816/jowd6519-16 · Cited by 3
Billy-Brissac, R., Phiraî, S., Larifla, L., Atallah, A., Hédreville, M., Hedreville, S., Fassih, M., Cadélis, G., Rhinan, P., Soter, V., et al. (2015) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2015.04.010 · Cited by 3
Novel Promoter Polymorphism in RUNX2 Is Associated with Serum Triglyceride Level
Shin, H. D., Jeon, J., Park, B. L., et al. (2008) · Molecules and Cells · doi:10.1016/s1016-8478(23)14022-2 · Cited by 3
Islet Volume and Indexes of β-Cell Function in Humans
Nano, R., Melzi, R., Mercalli, A., Balzano, G., Scavini, M., Bonadonna, R. C., & Piemonti, L. (2016) · Cell Transplantation · doi:10.3727/096368915x688498 · Cited by 4
Lanzi, C. R., de Rosas, I., Perdicaro, D. J., Ponce, M. T., Martínez, L., Miatello, R. M., Cavagnaro, B., & Prieto, M. A. V. (2016) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2016.1207060 · Cited by 4
Clinical Decision Support System for Diabetes Prevention
Shrestha, S. (2013) · IGI Global eBooks · doi:10.4018/978-1-4666-2671-3.ch017 · Cited by 3
Mohammadi, S., Ebrahimi‐Mameghani, M., Arefhosseini, S. R., Fallah, P., Jafarabadi, M. A., Vahed, S. Z., Soleimani, M., Dehkordi, M. B., & Ghanbarian, H. (2016) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.37521 · Cited by 4
Obstructive Sleep Apnea and Metabolic Dysfunction
Polotsky, V. Y., Jun, J. C., & Punjabi, N. M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6645-3.00114-6 · Cited by 5
The APJ Receptor A445C C Mutant Carrier Improves HDL Metabolism in Korean CVD Patients
Park, K., & Jang, Y. (2016) · Journal of Clinical & Experimental Cardiology · doi:10.4172/2155-9880.1000446 · Cited by 3
Florez, J. C., Udler, M. S., & Hanson, R. L. (2021) · Europe PMC (PubMed Central) · Cited by 3
Ahmed, H. H., Metwally, F. M., Rashad, H. M., & Zaazaa, A. M. (2016) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2016.v9s2.13674 · Cited by 3
Shehata, M. I., Ahmed, S., Mahmoud, R. S. G., et al. (2015) · Zagazig University Medical Journal · Cited by 3
Wilbaux, M., Wölnerhanssen, B. K., Meyer‐Gerspach, A. C., Beglinger, C., & Pfister, M. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00369.2016 · Cited by 3
Elevated fasting insulin levels increase the risk of abdominal obesity in Korean men
Park, S. K., Oh, C., Jung, T., Choi, Y., Chung, J. Y., & Ryoo, J. (2017) · Maturitas · doi:10.1016/j.maturitas.2017.01.001 · Cited by 3
Yalçın, H., Toprak, B., & Çolak, A. (2017) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2016-0256 · Cited by 3
Glucose Tolerance is Improved Following Surgery for Silent Somatotroph Adenoma
Miya, A. (2015) · International Journal of Diabetes and Clinical Research · doi:10.23937/2377-3634/1410047 · Cited by 3
Effect of oxyquinoline ointment on diaper dermatitis.
Minnich, S. M., Moeschberger, M. L., & Anderson, J. H. (1991) · PubMed · Cited by 3
Hitsumoto, T. (2017) · Diabetology International · doi:10.1007/s13340-017-0329-8 · Cited by 3
Hanafy, A. S. (2017) · Cytokine · doi:10.1016/j.cyto.2017.08.002 · Cited by 3
Li, L., Yoshitomi, H., Lingling, Q., Xinli, W., Tian, Z., Haiyan, W., Yueying, J., Ying, W., Xu, T., Tonghua, L., et al. (2017) · 中医杂志：英文版 · doi:10.1016/s0254-6272(17)30072-9 · Cited by 3
Trajectories of Postload Plasma Glucose in the Development of Type 2 Diabetes in Japanese Adults
Oka, R., Shibata, K., Sakurai, M., Kometani, M., Yamagishi, M., Yoshimura, K., & Yoneda, T. (2017) · Journal of Diabetes Research · doi:10.1155/2017/5307523 · Cited by 3
Insulin Resistance is Associated with Chronic Laryngitis in Korean Women
Cho, J.-H., Lee, S.-S., Han, K., et al. (2017) · The journal of nutrition health & aging · doi:10.1007/s12603-017-0972-6 · Cited by 3
Association Between Haptoglobin Gene and Insulin Resistance in Arab–Americans
Burghardt, K. J., Masri, D. E., Dass, S. E., et al. (2017) · Biomarkers in Medicine · doi:10.2217/bmm-2017-0094 · Cited by 3
Liu, T., Li, C., Shen, L., Shen, Y., Mao, W., & Li, S. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.12.012 · Cited by 3
Combining Various Methods to Assess Insulin Sensitivity in Nonobese Rat after Sleeve Gastrectomy
Sun, D., Wang, Y., Meng, W., et al. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-125315 · Cited by 3
Cardiotrophin-1 as a new metabolic biomarker in women with PCOS
İlhan, G. A., Kanlioglu, C., Arslan, G., et al. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1457637 · Cited by 3
Li, Y., Sheu, W. H., Lee, W., Lee, I., Lin, S., Lee, W.-L., Liang, K., & Wang, J. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0846 · Cited by 3
Prevalence and complications of obesity and overweight among Algerian adolescents
Benmohammed, K., Valensi, P. E., Nguyen, M. T., Benmohammed, F., & Lezzar, A. (2018) · Mediterranean Journal of Nutrition and Metabolism · doi:10.3233/mnm-17173 · Cited by 3
Lutz, S. Z., Falcenberg, M., Machicao, F. E., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26055-7 · Cited by 3
Wilson, J. W., Docherty, P. D., Stubbs, R., et al. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0603-3539 · Cited by 3
Relationship of the hs-CRP Levels with FBG, Fructosamine, and HbA1c in Non-diabetic Obesity Adults
Oh, H. J., & Choi, C. W. (2018) · Korean Journal of Clinical Laboratory Science · doi:10.15324/kjcls.2018.50.2.190 · Cited by 3
Osei, K., & Gaillard, T. R. (2018) · Journal of the National Medical Association · doi:10.1016/j.jnma.2018.06.004 · Cited by 3
Suzuki, T., Takebayashi, K., Hara, K., Tsuchiya, T., & Inukai, T. (2018) · Journal of International Medical Research · doi:10.1177/0300060518791067 · Cited by 3
Abdel‐Rahman, A. A. ‐., Abdel‐Megied, A. E. ‐., Elbaz, R., Wafa, A. M., & zekred, A. S. E. (2018) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2018v10i9.22747 · Cited by 3
Is it Possible to Easily Identify Metabolically Healthy Obese Women?
Scorsatto, M., Rosa, G., Pimentel, A. D. C., Luiz, R. R., & de Oliveira, G. M. M. (2018) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20180228 · Cited by 3
Ibrahim, S. M. (2015) · Endocrinology&Metabolism International Journal · doi:10.15406/emij.2015.02.00018 · Cited by 3
Martin, S., Colle, R., Asmar, K. E., Rigal, A., Vievard, A., Fève, B., Becquemont, L., Verstuyft, C., & Corruble, E. (2018) · Psychological Medicine · doi:10.1017/s0033291718003240 · Cited by 3
Demidova, T. Y., As, A., & Smagina, L. V. (2004) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2004-10-2-104-109 · Cited by 3
Health indicators and costs among outpatients according to physical activity level and obesity
de Morais, L. C., Rocha, A. P. R., Turi-Lynch, B. C., Ferro, I. D. S., Koyama, K. A. K., Araújo, M. Y. C., & Codogno, J. S. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.02.018 · Cited by 3
Long-term parameters of heart rate variability in patients with insulin-resistance
Novo, G., Manno, G., Levantino, P., et al. (2019) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000798 · Cited by 3
TNF-Related Apoptosis-Inducing Ligand Receptor 1 in Patients With Ankylosing Spondylitis
Karadağ, D. T., Tekeoğlu, S., Yazici, A., Işık, Ö. Ö., Eraldemir, F. C., & Çefle, A. (2019) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000001050 · Cited by 3
Larger omental adipocytes correlate with greater Fetuin-A reduction following sleeve gastrectomy
Robinson, K. N., Rowitz, B. M., Oliphant, U. J., Donovan, S. M., & Terán-Garcı́a, M. (2019) · BMC Obesity · doi:10.1186/s40608-019-0238-4 · Cited by 3
신중달 (2010) · 대한무도학회지 · doi:10.35277/kama.2010.12.2.253 · Cited by 3
High Sugar-Fat Diet Induces Metabolic-Inflammatory Disorders Independent of Obesity Development
Garcia, J. L., Francisqueti‐Ferron, F. V., Ferraz, A. P. C. R., Ferron, A. J. T., Costa, M. R., Gregolin, C. S., de Campos, D. H. S., dos Santos, K. C., Minatel, I. O., & Corrêa, C. R. (2019) · Food and Nutrition Sciences · doi:10.4236/fns.2019.106049 · Cited by 3
Jung, B. J., Lee, M. Y., & Jeon, S. (2019) · Journal of Ophthalmology · doi:10.1155/2019/4831967 · Cited by 3
Pelvic osteoid osteoma in a skeletally mature female.
Amanatullah, D. F., Mallon, Z. O., Mak, W. H., Borys, D., & Tamurian, R. M. (2011) · PubMed · Cited by 3
Effect of AqueousTerminalia sericeaLeaf Extract on Visceral Obesity in Fructose-fed Wistar Rats
Lembede, B. W., Erlwanger, K. H., & Chivandi, E. (2019) · Journal of Herbs Spices & Medicinal Plants · doi:10.1080/10496475.2019.1645074 · Cited by 3
Vijayan, A., Varma, K. K., Bhagyanathan, M., Dinesh, K., Nath, K. R. D., & Bijayraj, R. (2011) · Medical Practice and Reviews · doi:10.5897/mpr.9000016 · Cited by 3
Castro, T. D. F., Gomes, S. F., Silva, F. C. S., de Oliveira, F. L. P., do Amaral, J. F., Previato, H. D. R. D. A., de Freitas, R. N., & Volp, A. C. P. (2019) · Nutrition & Food Science · doi:10.1108/nfs-11-2018-0321 · Cited by 3
Bilginoğlu, A. (2019) · Journal of Contemporary Medicine · doi:10.16899/jcm.575413 · Cited by 3
Study of diabetes mellitus among patients with hepatitis C virus
Raouf, M. A., Yousry, Z. A., Hindy, O. M., et al. (2012) · The Egyptian Journal of Internal Medicine · doi:10.7123/01.ejim.0000415588.62804.fc · Cited by 3
Insulin Resistance Among Pregnant Women in Urban Areas of Arusha Region, Tanzania
Msollo, S. S., Martin, H., Mwanri, A. W., & Petrucka, P. M. (2019) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2019.0077 · Cited by 3
Spectrum of lipid and lipoprotein indices in human subjects with insulin resistance syndrome.
Khan, S. H., Khan, F. A., Ijaz, A., Sattar, A., Dilawar, M., & Hashim, R. (2008) · PubMed · Cited by 3
Costa, J. D. A., Gomes, J. M. G., Ribeiro, P. V. D. M., & Alfenas, R. D. C. G. (2019) · British Journal Of Nutrition · doi:10.1017/s0007114519003192 · Cited by 4
El-Alameey, I. R., Ahmed, H. H., & AbuShady, M. M. (2019) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/1799 · Cited by 3
Yu, Y., Pan, F., Cui, W., Tang, W., & Hu, Y. (2020) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13861 · Cited by 3
Li, B., Hu, Y., Wang, G., & Liu, L. (2020) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-020-00422-5 · Cited by 4
Joo, H.-W., Song, Y.-S., Park, I.-H., et al. (2020) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2020/2156829 · Cited by 3
Anderson, J. R., Maki, K. C., Palacios, O. M., Edirisinghe, I., Burton‐Freeman, B. M., & Spitznagel, M. B. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02343-9 · Cited by 3
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
